Bariatric Surgery Linked to Improved IBD Outcomes in Patients With Obesity

Follow Drugslib on

By Elana Gotkine HealthDay Reporter

Medically reviewed by Drugs.com

via HealthDay

THURSDAY, Aug. 21, 2025 -- For patients with inflammatory bowel disease and obesity, bariatric surgery is associated with improved inflammatory bowel disease-related outcomes, according to a study published online July 22 in BJS Open.

Erik Stenberg, M.D., from Örebro University in Sweden, and colleagues conducted a nationwide cohort study involving all adult patients in Sweden between 2007 and 2020 with obesity and inflammatory bowel disease. A two-stage process was used to match those undergoing bariatric surgery with those who were not.

A total of 798 patients with inflammatory bowel disease and obesity were included: 399 underwent bariatric surgery and 399 did not. The researchers found that the composite primary end point (inflammatory bowel disease-related hospitalization, initiation of corticosteroid therapy, immunomodulation, commencement of a new targeted therapy, or major inflammatory bowel disease-related surgery) occurred in 201 and 226 patients who had surgery and did not have surgery, respectively (incidence rate, 11.9 and 15.1 per 100 person-years), corresponding to a hazard ratio of 0.66 for those undergoing bariatric surgery.

"Bariatric surgery was associated with a lower risk of worsening IBD. The risk was reduced both in ulcerative colitis and in Crohn's disease," the authors write. "A similar tendency was seen after sleeve gastrectomy as well as Roux-en-Y gastric bypass, but the results were statistically significant only after Roux-en-Y gastric bypass surgery."

Several authors disclosed ties to the pharmaceutical industry.

Abstract/Full Text

Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.

Source: HealthDay

Posted : 2025-08-22 06:00

Read more

Disclaimer

Every effort has been made to ensure that the information provided by Drugslib.com is accurate, up-to-date, and complete, but no guarantee is made to that effect. Drug information contained herein may be time sensitive. Drugslib.com information has been compiled for use by healthcare practitioners and consumers in the United States and therefore Drugslib.com does not warrant that uses outside of the United States are appropriate, unless specifically indicated otherwise. Drugslib.com's drug information does not endorse drugs, diagnose patients or recommend therapy. Drugslib.com's drug information is an informational resource designed to assist licensed healthcare practitioners in caring for their patients and/or to serve consumers viewing this service as a supplement to, and not a substitute for, the expertise, skill, knowledge and judgment of healthcare practitioners.

The absence of a warning for a given drug or drug combination in no way should be construed to indicate that the drug or drug combination is safe, effective or appropriate for any given patient. Drugslib.com does not assume any responsibility for any aspect of healthcare administered with the aid of information Drugslib.com provides. The information contained herein is not intended to cover all possible uses, directions, precautions, warnings, drug interactions, allergic reactions, or adverse effects. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.

Popular Keywords